Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon alpha-2b for glucocorticoid-refractory Diamond-Blackfan anemia in children
ChiCTR2000038510Phase 4Not yet recruiting
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Sep 2020
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of interferon alfa-2b in Diamond-Blackfan anemia (DBA), sponsored by Institute of Hematology and Blood Diseases Hospital. Primary endpoints: Blood routine examination and Absolute value of reticulocyte. Planned start Sep 2020; status: not yet recruiting.
02
Drugs
interferon alfa-2b
03
Conditions
Diamond-Blackfan anemia (DBA)
Beyond the preview
Go deeper on ChiCTR2000038510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038510.